Stay ahead of developments in federal and state health care law, regulation and transactions with timely, expert news and analysis.
Oct. 26 — A new FDA Web page could make it easier for the public to submit complaints about possible regulatory misconduct related to medical devices.
The Food and Drug Administration says the redesigned reporting channel aims to simplify the process for filing device-related complaints, but one regulatory lawyer warns the revamped gateway could increase the number of unfounded complaints.
“With this website, FDA may find itself flooded with low quality, unsubstantiated allegations that will create an unproductive distraction for the agency and device manufacturers,” Gregory H. Levine of Ropes & Gray LLP, Washington, told Bloomberg BNA Oct. 25.
Sonali Gunawardhana, an attorney with Wiley Rein in Washington, said the new system could result in more complaints being filed by disgruntled employees as well as more complaints whose allegations can’t be verified. She said the agency may have adequate staff to review an increased number of complaints but may lack the resources to investigate them. Gunawardhana formerly worked at the FDA.
Stephanie Caccomo, a press officer with the FDA, told Bloomberg BNA Oct. 25 the agency intends to keep an eye on the complaint numbers. “The FDA will monitor how the online submission process impacts the number of allegations of regulatory misconduct filed,” she said.
Caccomo said the agency developed the Web page “to provide the public with more information on reporting allegations of regulatory misconduct related to medical devices and provide clear instructions for reporting to the FDA.”
The website explains the process for submitting allegations to the FDA’s Center for Devices and Radiological Health (CDRH) and includes a new online form to simplify the submission process, she said.
Although the agency’s online public reporting portal is new, the FDA has always received these types of complaints in the device area.
The FDA doesn’t think the public was discouraged from filing allegations in the past, Caccomo said, but it “expects the public will find the online submission process ... easier to use,” she said.
“The FDA has always taken emails and calls in regard to allegations,” Gunawardhana said.
Gunawardhana said most of the complaints the FDA receives are made by device company employees or by patients who allege they were harmed rather than by companies.
For his part, Levine said, he was “surprised to see” the FDA’s new online process. “I didn’t think FDA was facing a shortage of complaints from the public alleging regulatory violations by manufacturers.”
Meanwhile, Levine said, “FDA also has announced no improvement in its unsatisfying and untimely process for informing submitters of the outcome of their complaints, telling them to wait six months and submit a FOIA [Freedom of Information Act] request.”
To contact the reporter on this story: Dana A. Elfin in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Brian Broderick at email@example.com
The new FDA Web page is at http://src.bna.com/jBH.
Copyright © 2016 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)